ReviewCurrent addiction reports2026
Joint Relations Among Cannabis, Sleep, and Affective Symptomatology: A Scoping Review.
Review in Current addiction reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Purpose of Review: This scoping review used a five-stage framework to evaluate empirical studies positing anxiety and depression as mechanisms or moderators in associations between cannabis use and sleep. Applicable peer-reviewed studies were identified in Google Scholar and PubMed using relevant search terms (e.g., cannabis, sleep, depression, anxiety). Recent Findings: Of the 20 articles included, most examined cannabis effects on sleep using prospective designs with adults recruited based on anxiety and/or depression symptomatology. Fewer studies tested bidirectional associations between cannabis and sleep. Among adults reporting clinically significant symptoms of anxiety and depression at baseline, certain cannabis product formulations were associated with concurrent and prospective improvements in subjective sleep phenotypes. However, this pattern of findings was not evident among those without anxiety/depression, none of the designs were experimental, and only one study included objective sleep measures. Summary: Providers should be aware that cannabis' perceived sleep benefits are more pronounced among those with anxiety/depressive disorders. Experimental research with objective measures testing how and for whom sleep and cannabis are linked is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.